Table 5b.
Hippocampus plasmalogen mass in SSADH deficient patient and control group
| nmol/g ww | mol % | |||||
|---|---|---|---|---|---|---|
|
|
||||||
| Patient | Mean (control) | SD | Patient | Mean (control) | SD | |
|
|
||||||
| EtnGpl | 6933 | 8815 | 1331 | 59.4% | 36.9% | 10.2% |
| PlsEtn | 4734 | 15593 | 3986* | 40.6% | 63.1% | 10.2%* |
| ChoGpl | 9728 | 15751 | 2256* | 89.9% | 88.5% | 4.3% |
| PlsCho | 1096 | 1979 | 530 | 10.1% | 11.5% | 4.3% |
| n = 1 | n = 4 | |||||
Mass values are expressed as nmol phosphorus/gram wet weight tissue and represent mean±SD of control and patient values. Molar composition values are expressed as mol % of total phosphorus. n = 2–4.
*
indicates significance between patient and control group, 2 SD from control mean.